» Articles » PMID: 39408969

Evaluation of Retinal Structure and Visual Function in Blue Cone Monochromacy to Develop Clinical Endpoints for L-opsin Gene Therapy

Abstract

L-cone opsin expression by gene therapy is a promising treatment for blue cone monochromacy (BCM) caused by congenital lack of long- and middle-wavelength-sensitive (L/M) cone function. Eight patients with BCM and confirmed pathogenic variants at the OPN1LW/OPN1MW gene cluster participated. Optical coherence tomography (OCT), chromatic perimetry, chromatic microperimetry, chromatic visual acuity (VA), and chromaticity thresholds were performed with unmodified commercial equipment and/or methods available in the public domain. Adaptive optics scanning laser ophthalmoscope (AOSLO) imaging was performed in a subset of patients. Outer retinal changes were detectable by OCT with an age-related effect on the foveal disease stage. Rod and short-wavelength-sensitive (S) cone functions were relatively retained by perimetry, although likely impacted by age-related increases in the pre-retinal absorption of short-wavelength lights. The central macula showed a large loss of red sensitivity on dark-adapted microperimetry. Chromatic VAs with high-contrast red gratings on a blue background were not detectable. Color vision was severely deficient. AOSLO imaging showed reduced total cone density with majority of the population being non-waveguiding. This study developed and evaluated specialized outcomes that will be needed for the determination of efficacy and safety in human clinical trials. Dark-adapted microperimetry with a red stimulus sampling the central macula would be a key endpoint to evaluate the light sensitivity improvements. VA changes specific to L-opsin can be measured with red gratings on a bright blue background and should also be considered as outcome measures in future interventional trials.

References
1.
Simunovic M, Hess K, Avery N, Mammo Z . Threshold versus intensity functions in two-colour automated perimetry. Ophthalmic Physiol Opt. 2020; 41(1):157-164. DOI: 10.1111/opo.12743. View

2.
Cideciyan A, Swider M, Aleman T, Roman M, Sumaroka A, Schwartz S . Reduced-illuminance autofluorescence imaging in ABCA4-associated retinal degenerations. J Opt Soc Am A Opt Image Sci Vis. 2007; 24(5):1457-67. PMC: 2579898. DOI: 10.1364/josaa.24.001457. View

3.
Mascio A, Roman A, Cideciyan A, Sheplock R, Wu V, Garafalo A . Color Vision in Blue Cone Monochromacy: Outcome Measures for a Clinical Trial. Transl Vis Sci Technol. 2023; 12(1):25. PMC: 9896867. DOI: 10.1167/tvst.12.1.25. View

4.
Cideciyan A, Jacobson S . Leber Congenital Amaurosis (LCA): Potential for Improvement of Vision. Invest Ophthalmol Vis Sci. 2019; 60(5):1680-1695. PMC: 6892385. DOI: 10.1167/iovs.19-26672. View

5.
Oertli J, Pfau K, Scholl H, Jeffrey B, Pfau M . Establishing Fully-Automated Fundus-Controlled Dark Adaptometry: A Validation and Retest-Reliability Study. Transl Vis Sci Technol. 2023; 12(12):18. PMC: 10732091. DOI: 10.1167/tvst.12.12.18. View